0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Respiratory Distress Syndrome Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Published Date: June 2024
|
Report Code: QYRE-Auto-30X5534
Home | Market Reports | Health| Health Conditions| Respiratory Conditions
Global Respiratory Distress Syndrome Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Respiratory Distress Syndrome Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030

Code: QYRE-Auto-30X5534
Report
June 2024
Pages:130
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Respiratory Distress Syndrome Market Size

The global market for Respiratory Distress Syndrome was estimated to be worth US$ 377.7 million in 2023 and is forecast to a readjusted size of US$ 551.9 million by 2030 with a CAGR of 5.5% during the forecast period 2024-2030.

Respiratory Distress Syndrome Market

Respiratory Distress Syndrome Market

Respiratory distress syndrome is caused by pulmonary surfactant deficiency in the lungs of neonates, most commonly in those born at < 37 weeks’ gestation. Risk increases with degree of prematurity. Symptoms and signs include grunting respirations, use of accessory muscles, and nasal flaring appearing soon after birth. Diagnosis is clinical; prenatal risk can be assessed with tests of fetal lung maturity. Treatment is surfactant therapy and supportive care. Treatment for RDS usually begins as soon as a newborn is born, sometimes in the delivery room. Treatments for RDS include surfactant replacement therapy, breathing support from a ventilator or nasal continuous positive airway pressure (NCPAP) machine, or other supportive treatments.
North America is the largest consumption place, with a consumption market share nearly 33% . Following North America, China is the second largest consumption place with the consumption market share of 26%.The key manufacturers are Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen etc. Top 3 companies occupied about 85% market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Respiratory Distress Syndrome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Respiratory Distress Syndrome.
The Respiratory Distress Syndrome market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Respiratory Distress Syndrome market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Distress Syndrome companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Respiratory Distress Syndrome Market Report

Report Metric Details
Report Name Respiratory Distress Syndrome Market
Forecasted market size in 2030 US$ 551.9 million
CAGR 5.5%
Forecasted years 2024 - 2030
Segment by Type
  • Poractant Alfa
  • Beractant
  • Calfactant
  • Others
Segment by Application
  • Very Preterm Infants
  • Moderate to Late Preterm Infants
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Respiratory Distress Syndrome in global and regional level.
  • Chapter 3: Detailed analysis of Respiratory Distress Syndrome company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Respiratory Distress Syndrome revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Respiratory Distress Syndrome Market size in 2030?

Ans: The Respiratory Distress Syndrome Market size in 2030 will be US$ 551.9 million.

What is the Respiratory Distress Syndrome Market share by region?

Ans: North America is the largest consumption place, with a consumption market share nearly 33% .

What is the market share of major companies in Respiratory Distress Syndrome Market?

Ans: Top 3 companies occupied about 85% market share.

Who are the main players in the Respiratory Distress Syndrome Market report?

Ans: The main players in the Respiratory Distress Syndrome Market are Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen

What are the Application segmentation covered in the Respiratory Distress Syndrome Market report?

Ans: The Applications covered in the Respiratory Distress Syndrome Market report are Very Preterm Infants, Moderate to Late Preterm Infants, Others

What are the Type segmentation covered in the Respiratory Distress Syndrome Market report?

Ans: The Types covered in the Respiratory Distress Syndrome Market report are Poractant Alfa, Beractant, Calfactant, Others

1 Study Coverage
1.1 Respiratory Distress Syndrome Product Introduction
1.2 Market by Type
1.2.1 Global Respiratory Distress Syndrome Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Poractant Alfa
1.2.3 Beractant
1.2.4 Calfactant
1.2.5 Others
1.3 Market by Application
1.3.1 Global Respiratory Distress Syndrome Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Very Preterm Infants
1.3.3 Moderate to Late Preterm Infants
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Respiratory Distress Syndrome Market Size Estimates and Forecasts
2.2 Respiratory Distress Syndrome Market Size by Region: 2023 Versus 2030
2.2.1 Global Respiratory Distress Syndrome Revenue by Region: 2019-2024
2.2.2 Global Respiratory Distress Syndrome Revenue Forecast by Region (2025-2030)
2.2.3 Global Respiratory Distress Syndrome Revenue Market Share by Region (2019-2030)
3 Global Respiratory Distress Syndrome by Company
3.1 Global Respiratory Distress Syndrome Revenue by Company (2019-2024)
3.2 Global Respiratory Distress Syndrome Revenue Share by Company (2019-2024)
3.3 Competitive Landscape
3.3.1 Key Respiratory Distress Syndrome Companies around the World: Ranking by Revenue
3.3.2 Global Respiratory Distress Syndrome Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.3.3 Global Respiratory Distress Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Respiratory Distress Syndrome Companies Headquarters & Product Type
3.4.1 Respiratory Distress Syndrome Companies Headquarters
3.4.2 Global Respiratory Distress Syndrome Companies Product & Service
3.4.3 Date of International Companies Enter into Respiratory Distress Syndrome Market
3.5 Global Respiratory Distress Syndrome Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Chiesi Farmaceutici
4.1.1 Chiesi Farmaceutici Company Information
4.1.2 Chiesi Farmaceutici Description, Business Overview
4.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Products Offered
4.1.4 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue and Gross Margin (2019-2024)
4.1.5 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue by Product in 2023
4.1.6 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue by Application in 2023
4.1.7 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue by Geographic Area in 2023
4.1.8 Chiesi Farmaceutici Recent Developments
4.2 CR-Double Crane
4.2.1 CR-Double Crane Company Information
4.2.2 CR-Double Crane Description, Business Overview
4.2.3 CR-Double Crane Respiratory Distress Syndrome Products Offered
4.2.4 CR-Double Crane Respiratory Distress Syndrome Revenue and Gross Margin (2019-2024)
4.2.5 CR-Double Crane Respiratory Distress Syndrome Revenue by Product in 2023
4.2.6 CR-Double Crane Respiratory Distress Syndrome Revenue by Application in 2023
4.2.7 CR-Double Crane Respiratory Distress Syndrome Revenue by Geographic Area in 2023
4.2.8 CR-Double Crane Recent Developments
4.3 ONY Biotech
4.3.1 ONY Biotech Company Information
4.3.2 ONY Biotech Description, Business Overview
4.3.3 ONY Biotech Respiratory Distress Syndrome Products Offered
4.3.4 ONY Biotech Respiratory Distress Syndrome Revenue and Gross Margin (2019-2024)
4.3.5 ONY Biotech Respiratory Distress Syndrome Revenue by Product in 2023
4.3.6 ONY Biotech Respiratory Distress Syndrome Revenue by Application in 2023
4.3.7 ONY Biotech Respiratory Distress Syndrome Revenue by Geographic Area in 2023
4.3.8 ONY Biotech Recent Developments
4.4 AbbVie
4.4.1 AbbVie Company Information
4.4.2 AbbVie Description, Business Overview
4.4.3 AbbVie Respiratory Distress Syndrome Products Offered
4.4.4 AbbVie Respiratory Distress Syndrome Revenue and Gross Margin (2019-2024)
4.4.5 AbbVie Respiratory Distress Syndrome Revenue by Product in 2023
4.4.6 AbbVie Respiratory Distress Syndrome Revenue by Application in 2023
4.4.7 AbbVie Respiratory Distress Syndrome Revenue by Geographic Area in 2023
4.4.8 AbbVie Recent Developments
4.5 Yuhan Corporation
4.5.1 Yuhan Corporation Company Information
4.5.2 Yuhan Corporation Description, Business Overview
4.5.3 Yuhan Corporation Respiratory Distress Syndrome Products Offered
4.5.4 Yuhan Corporation Respiratory Distress Syndrome Revenue and Gross Margin (2019-2024)
4.5.5 Yuhan Corporation Respiratory Distress Syndrome Revenue by Product in 2023
4.5.6 Yuhan Corporation Respiratory Distress Syndrome Revenue by Application in 2023
4.5.7 Yuhan Corporation Respiratory Distress Syndrome Revenue by Geographic Area in 2023
4.5.8 Yuhan Corporation Recent Developments
4.6 JW Pharmaceuticals
4.6.1 JW Pharmaceuticals Company Information
4.6.2 JW Pharmaceuticals Description, Business Overview
4.6.3 JW Pharmaceuticals Respiratory Distress Syndrome Products Offered
4.6.4 JW Pharmaceuticals Respiratory Distress Syndrome Revenue and Gross Margin (2019-2024)
4.6.5 JW Pharmaceuticals Respiratory Distress Syndrome Revenue by Product in 2023
4.6.6 JW Pharmaceuticals Respiratory Distress Syndrome Revenue by Application in 2023
4.6.7 JW Pharmaceuticals Respiratory Distress Syndrome Revenue by Geographic Area in 2023
4.6.8 JW Pharmaceuticals Recent Development
4.7 Noargen
4.7.1 Noargen Company Information
4.7.2 Noargen Description, Business Overview
4.7.3 Noargen Respiratory Distress Syndrome Products Offered
4.7.4 Noargen Respiratory Distress Syndrome Revenue and Gross Margin (2019-2024)
4.7.5 Noargen Respiratory Distress Syndrome Revenue by Product in 2023
4.7.6 Noargen Respiratory Distress Syndrome Revenue by Application in 2023
4.7.7 Noargen Respiratory Distress Syndrome Revenue by Geographic Area in 2023
4.7.8 Noargen Recent Development
5 Breakdown Data by Type
5.1 Global Respiratory Distress Syndrome Revenue by Type (2019-2024)
5.2 Global Respiratory Distress Syndrome Revenue Forecast by Type (2025-2030)
5.3 Respiratory Distress Syndrome Revenue Market Share by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Respiratory Distress Syndrome Revenue by Application (2019-2024)
6.2 Global Respiratory Distress Syndrome Revenue Forecast by Application (2025-2030)
6.3 Respiratory Distress Syndrome Revenue Market Share by Application (2019-2030)
7 North America
7.1 North America Respiratory Distress Syndrome Market Size YoY Growth 2019-2030
7.2 North America Respiratory Distress Syndrome Market Facts & Figures by Country (2019-2030)
7.3 North America Respiratory Distress Syndrome Revenue by Type (2019-2024)
7.4 North America Respiratory Distress Syndrome Revenue by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Distress Syndrome Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Respiratory Distress Syndrome Market Facts & Figures by Region (2019-2030)
8.3 Asia-Pacific Respiratory Distress Syndrome Revenue by Type (2019-2024)
8.4 Asia-Pacific Respiratory Distress Syndrome Revenue by Application (2019-2024)
9 Europe
9.1 Europe Respiratory Distress Syndrome Market Size YoY Growth 2019-2030
9.2 Europe Respiratory Distress Syndrome Market Facts & Figures by Country (2019-2030)
9.3 Europe Respiratory Distress Syndrome Revenue by Type (2019-2024)
9.4 Europe Respiratory Distress Syndrome Revenue by Application (2019-2024)
10 Latin America
10.1 Latin America Respiratory Distress Syndrome Market Size YoY Growth 2019-2030
10.2 Latin America Respiratory Distress Syndrome Market Facts & Figures by Country (2019-2030)
10.3 Latin America Respiratory Distress Syndrome Revenue by Type (2019-2024)
10.4 Latin America Respiratory Distress Syndrome Revenue by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Respiratory Distress Syndrome Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Respiratory Distress Syndrome Market Facts & Figures by Country (2019-2030)
11.3 Middle East and Africa Respiratory Distress Syndrome Revenue by Type (2019-2024)
11.4 Middle East and Africa Respiratory Distress Syndrome Revenue by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Respiratory Distress Syndrome Supply Chain Analysis
12.2 Respiratory Distress Syndrome Key Raw Materials and Upstream Suppliers
12.3 Respiratory Distress Syndrome Clients Analysis
12.4 Respiratory Distress Syndrome Sales Channel and Sales Model Analysis
12.4.1 Respiratory Distress Syndrome Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Respiratory Distress Syndrome Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Respiratory Distress Syndrome Distributors
13 Market Dynamics
13.1 Respiratory Distress Syndrome Industry Trends
13.2 Respiratory Distress Syndrome Market Drivers
13.3 Respiratory Distress Syndrome Market Challenges
13.4 Respiratory Distress Syndrome Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Respiratory Distress Syndrome Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Major Companies of Poractant Alfa
    Table 3. Major Companies of Beractant
    Table 4. Major Companies of Calfactant
    Table 5. Major Companies of Others
    Table 6. Global Respiratory Distress Syndrome Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Respiratory Distress Syndrome Market Size by Region (US$ Million): 2023 VS 2030
    Table 8. Global Respiratory Distress Syndrome Revenue by Region (2019-2024) & (US$ Million)
    Table 9. Global Respiratory Distress Syndrome Revenue Forecast by Region (2025-2030) & (US$ Million)
    Table 10. Respiratory Distress Syndrome Revenue by Company (2019-2024) & (US$ Million)
    Table 11. Respiratory Distress Syndrome Revenue Share by Company (2019-2024)
    Table 12. Ranking of Global Top Respiratory Distress Syndrome Players by Revenue (US$ Million) in 2023
    Table 13. Global Respiratory Distress Syndrome Companies Market Concentration Ratio (CR5 and HHI) & (2019-2024)
    Table 14. Global Respiratory Distress Syndrome by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Respiratory Distress Syndrome as of 2023)
    Table 15. Global Respiratory Distress Syndrome Companies Headquarters
    Table 16. Global Respiratory Distress Syndrome Companies Product & Service
    Table 17. Date of International Companies Enter into Respiratory Distress Syndrome Market
    Table 18. Global Respiratory Distress Syndrome Mergers & Acquisitions, Expansion Plans
    Table 19. Chiesi Farmaceutici Company Information
    Table 20. Chiesi Farmaceutici Description and Business Overview
    Table 21. Chiesi Farmaceutici Respiratory Distress Syndrome Product
    Table 22. Chiesi Farmaceutici Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 23. Chiesi Farmaceutici Revenue Proportion of Respiratory Distress Syndrome by Product in 2023
    Table 24. Chiesi Farmaceutici Revenue Proportion of Respiratory Distress Syndrome by Application in 2023
    Table 25. Chiesi Farmaceutici Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2023
    Table 26. Chiesi Farmaceutici Recent Development
    Table 27. CR-Double Crane Company Information
    Table 28. CR-Double Crane Description and Business Overview
    Table 29. CR-Double Crane Respiratory Distress Syndrome Product
    Table 30. CR-Double Crane Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 31. CR-Double Crane Revenue Proportion of Respiratory Distress Syndrome by Product in 2023
    Table 32. CR-Double Crane Revenue Proportion of Respiratory Distress Syndrome by Application in 2023
    Table 33. CR-Double Crane Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2023
    Table 34. CR-Double Crane Recent Development
    Table 35. ONY Biotech Company Information
    Table 36. ONY Biotech Description and Business Overview
    Table 37. ONY Biotech Respiratory Distress Syndrome Product
    Table 38. ONY Biotech Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 39. ONY Biotech Revenue Proportion of Respiratory Distress Syndrome by Product in 2023
    Table 40. ONY Biotech Revenue Proportion of Respiratory Distress Syndrome by Application in 2023
    Table 41. ONY Biotech Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2023
    Table 42. ONY Biotech Recent Development
    Table 43. AbbVie Company Information
    Table 44. AbbVie Description and Business Overview
    Table 45. AbbVie Respiratory Distress Syndrome Product
    Table 46. AbbVie Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 47. AbbVie Revenue Proportion of Respiratory Distress Syndrome by Product in 2023
    Table 48. AbbVie Revenue Proportion of Respiratory Distress Syndrome by Application in 2023
    Table 49. AbbVie Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2023
    Table 50. AbbVie Recent Development
    Table 51. Yuhan Corporation Company Information
    Table 52. Yuhan Corporation Description and Business Overview
    Table 53. Yuhan Corporation Respiratory Distress Syndrome Product
    Table 54. Yuhan Corporation Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 55. Yuhan Corporation Revenue Proportion of Respiratory Distress Syndrome by Product in 2023
    Table 56. Yuhan Corporation Revenue Proportion of Respiratory Distress Syndrome by Application in 2023
    Table 57. Yuhan Corporation Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2023
    Table 58. Yuhan Corporation Recent Development
    Table 59. JW Pharmaceuticals Company Information
    Table 60. JW Pharmaceuticals Description and Business Overview
    Table 61. JW Pharmaceuticals Respiratory Distress Syndrome Product
    Table 62. JW Pharmaceuticals Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 63. JW Pharmaceuticals Revenue Proportion of Respiratory Distress Syndrome by Product in 2023
    Table 64. JW Pharmaceuticals Revenue Proportion of Respiratory Distress Syndrome by Application in 2023
    Table 65. JW Pharmaceuticals Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2023
    Table 66. JW Pharmaceuticals Recent Development
    Table 67. Noargen Company Information
    Table 68. Noargen Description and Business Overview
    Table 69. Noargen Respiratory Distress Syndrome Product
    Table 70. Noargen Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 71. Noargen Revenue Proportion of Respiratory Distress Syndrome by Product in 2023
    Table 72. Noargen Revenue Proportion of Respiratory Distress Syndrome by Application in 2023
    Table 73. Noargen Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2023
    Table 74. Noargen Recent Development
    Table 75. Global Respiratory Distress Syndrome Revenue by Type (2019-2024) & (US$ Million)
    Table 76. Global Respiratory Distress Syndrome Revenue Forecast by Type (2025-2030) & (US$ Million)
    Table 77. Global Respiratory Distress Syndrome Revenue by Application (2019-2024) & (US$ Million)
    Table 78. Global Respiratory Distress Syndrome Revenue Forecast by Application (2025-2030) & (US$ Million)
    Table 79. North America Respiratory Distress Syndrome Revenue by Country (2019-2024) & (US$ Million)
    Table 80. North America Respiratory Distress Syndrome Revenue by Country (2025-2030) & (US$ Million)
    Table 81. North America Respiratory Distress Syndrome Revenue by Type (2019-2024) & (US$ Million)
    Table 82. North America Respiratory Distress Syndrome Revenue by Application (2019-2024) & (US$ Million)
    Table 83. Asia-Pacific Respiratory Distress Syndrome Revenue by Region (2019-2030) & (US$ Million)
    Table 84. Asia-Pacific Respiratory Distress Syndrome Revenue by Region (2025-2030) & (US$ Million)
    Table 85. Asia-Pacific Respiratory Distress Syndrome Revenue by Type (2019-2024) & (US$ Million)
    Table 86. Asia-Pacific Respiratory Distress Syndrome Revenue by Application (2019-2024) & (US$ Million)
    Table 87. Europe Respiratory Distress Syndrome Revenue by Country (2019-2024) & (US$ Million)
    Table 88. Europe Respiratory Distress Syndrome Revenue by Country (2025-2030) & (US$ Million)
    Table 89. Europe Respiratory Distress Syndrome Revenue by Type (2019-2024) & (US$ Million)
    Table 90. Europe Respiratory Distress Syndrome Revenue by Application (2019-2024) & (US$ Million)
    Table 91. Latin America Respiratory Distress Syndrome Revenue by Country (2019-2024) & (US$ Million)
    Table 92. Latin America Respiratory Distress Syndrome Revenue by Country (2025-2030) & (US$ Million)
    Table 93. Latin America Respiratory Distress Syndrome Revenue by Type (2019-2024) & (US$ Million)
    Table 94. Latin America Respiratory Distress Syndrome Revenue by Application (2019-2024) & (US$ Million)
    Table 95. Middle East and Africa Respiratory Distress Syndrome Revenue by Country (2019-2024) & (US$ Million)
    Table 96. Middle East and Africa Respiratory Distress Syndrome Revenue by Country (2025-2030) & (US$ Million)
    Table 97. Middle East and Africa Respiratory Distress Syndrome Revenue by Type (2019-2024) & (US$ Million)
    Table 98. Middle East and Africa Respiratory Distress Syndrome Revenue by Application (2019-2024) & (US$ Million)
    Table 99. Respiratory Distress Syndrome Key Raw Materials, Industry Status and Trend
    Table 100. Respiratory Distress Syndrome Key Raw Materials and Upstream Suppliers
    Table 101. Respiratory Distress Syndrome Clients Status and Trend
    Table 102. Respiratory Distress Syndrome Typical Clients
    Table 103. Respiratory Distress Syndrome Distributors
    Table 104. Respiratory Distress Syndrome Market Trends
    Table 105. Respiratory Distress Syndrome Market Drivers
    Table 106. Respiratory Distress Syndrome Market Challenges
    Table 107. Respiratory Distress Syndrome Market Restraints
    Table 108. Research Programs/Design for This Report
    Table 109. Key Data Information from Secondary Sources
    Table 110. Key Data Information from Primary Sources
List of Figures
    Figure 1. Respiratory Distress Syndrome Product Picture
    Figure 2. Global Respiratory Distress Syndrome Revenue Market Share by Type in 2023 & 2030
    Figure 3. Poractant Alfa Product Picture
    Figure 4. Beractant Product Picture
    Figure 5. Calfactant Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Respiratory Distress Syndrome Revenue Market Share by Application in 2023 & 2030
    Figure 8. Very Preterm Infants
    Figure 9. Moderate to Late Preterm Infants
    Figure 10. Others
    Figure 11. Respiratory Distress Syndrome Report Years Considered
    Figure 12. Global Respiratory Distress Syndrome Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Respiratory Distress Syndrome Market Size 2019-2030 (US$ Million)
    Figure 14. Global Respiratory Distress Syndrome Market Size Market Share by Region: 2023 Versus 2030
    Figure 15. Global Respiratory Distress Syndrome Revenue Market Share by Region (2019-2030)
    Figure 16. Respiratory Distress Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 17. Global Respiratory Distress Syndrome Revenue Market Share Forecast by Type (2019-2030)
    Figure 18. Global Respiratory Distress Syndrome Revenue Market Share Forecast by Application (2019-2030)
    Figure 19. North America Respiratory Distress Syndrome Revenue 2019-2030 (US$ Million)
    Figure 20. North America Respiratory Distress Syndrome Revenue Market Share by Type (2019-2024)
    Figure 21. North America Respiratory Distress Syndrome Revenue Market Share by Application (2019-2024)
    Figure 22. Asia-Pacific Respiratory Distress Syndrome Revenue 2019-2030 (US$ Million)
    Figure 23. Asia-Pacific Respiratory Distress Syndrome Revenue Market Share by Region (2019-2030)
    Figure 24. Asia-Pacific Respiratory Distress Syndrome Revenue Market Share by Type (2019-2024)
    Figure 25. Asia-Pacific Respiratory Distress Syndrome Revenue Market Share by Application (2019-2024)
    Figure 26. Europe Respiratory Distress Syndrome Revenue Growth Rate 2019-2030 (US$ Million)
    Figure 27. Europe Respiratory Distress Syndrome Revenue Market Share by Country (2019-2030)
    Figure 28. Europe Respiratory Distress Syndrome Revenue Market Share by Type (2019-2024)
    Figure 29. Europe Respiratory Distress Syndrome Revenue Market Share by Application (2019-2024)
    Figure 30. Latin America Respiratory Distress Syndrome Revenue Growth Rate 2019-2030 (US$ Million)
    Figure 31. Latin America Respiratory Distress Syndrome Revenue Market Share by Country (2019-2024)
    Figure 32. Latin America Respiratory Distress Syndrome Revenue Market Share by Type (2019-2024)
    Figure 33. Latin America Respiratory Distress Syndrome Revenue Market Share by Application (2019-2024)
    Figure 34. Middle East and Africa Respiratory Distress Syndrome Revenue Growth Rate 2019-2030 (US$ Million)
    Figure 35. Middle East and Africa Respiratory Distress Syndrome Revenue Market Share by Country (2019-2030)
    Figure 36. Middle East and Africa Respiratory Distress Syndrome Revenue Market Share by Type (2019-2024)
    Figure 37. Middle East and Africa Respiratory Distress Syndrome Revenue Market Share by Application (2019-2024)
    Figure 38. Respiratory Distress Syndrome Supply Chain (Upstream and Downstream Market)
    Figure 39. Global Production Market Share of Respiratory Distress Syndrome Raw Materials by Region in 2023
    Figure 40. Respiratory Distress Syndrome Distribution Channels
    Figure 41. Global Respiratory Distress Syndrome Percentage 2019-2030: Indirect Sales VS Direct Sales
    Figure 42. Global Respiratory Distress Syndrome Percentage 2019-2030: Online Sales VS Offline Sales
    Figure 43. Bottom-up and Top-down Approaches for This Report
    Figure 44. Data Triangulation
    Figure 45. Key Executives Interviewed
    Figure 46. Global Respiratory Distress Syndrome Percentage 2019-2030: Online Sales VS Offline Sales
    Figure 47. Bottom-up and Top-down Approaches for This Report
    Figure 48. Data Triangulation
    Figure 49. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Nitric Oxide Asthma Testing Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-9B6080
Fri Jul 12 00:00:00 UTC 2024

Add to Cart

Global Dyspnea Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4H6109
Tue Jun 11 00:00:00 UTC 2024

Add to Cart

Human Respiratory Disease Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-26I9547
Mon Jun 10 00:00:00 UTC 2024

Add to Cart

Global Spirometer Paper Mouthpiece Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-19H17456
Mon Jun 10 00:00:00 UTC 2024

Add to Cart